Corporate
Ultragenyx Crashes 44% After Setrusumab Fails Two Phase 3 Trials
Dec 29, 2025
You're signed outSign in or to get full access.
Ultragenyx Pharmaceutical (RARE) Earnings Call Transcripts
Browse quarterly earnings call transcripts for Ultragenyx Pharmaceutical.
Q3 2025
Nov 4, 2025
Q2 2025
Aug 5, 2025
Q1 2025
May 6, 2025
Q4 2024
Feb 13, 2025
Q3 2024
Nov 5, 2024